CVS Partially Dropping Top-Selling Drug Humira In Favor Of Cheaper Biosimilars
The drug generated $21 billion for AbbVie in 2022 and is projected to drop to $9 billion in sales this year.
Source: forbes.com
Stay updated with breaking news from Replace Abbvie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drug generated $21 billion for AbbVie in 2022 and is projected to drop to $9 billion in sales this year.